Conference
405 POSTER Final results of a Phase I/II study of CTCE-9908, a novel anticancer agent that inhibits CXCR4, in patients with advanced solid cancers
Authors
Hotte SJ; Hirte HW; Moretto P; Iacobucci A; Wong D; Korz W; Miller WH
Volume
6
Publisher
Elsevier
Publication Date
October 2008
DOI
10.1016/s1359-6349(08)72339-5
Conference proceedings
European Journal of Cancer Supplements
Issue
12
ISSN
1359-6349